Granted Patent B2

US 12,491,308 · App. 17/602,608 · Granted Dec 9, 2025

Inventors: Christopher Brian Locke (Bournemouth, GB); Timothy Mark Robinson (Shillingstone, GB)

Assignee: Solventum Intellectual Properties Company

A61M1/78A61F13/0223A61F13/05A61M1/912A61M1/915A61M1/964A61M1/92A61M1/985A61M2205/584

Abstract

Claims (17)

1 . A system for treating a tissue site, comprising:

a dressing, comprising:

a base layer including a periphery surrounding a central portion and a plurality of apertures disposed through the periphery and the central portion,

a sealing member including a periphery and a central portion, the periphery of the sealing member positioned proximate to the periphery of the base layer, the central portion of the sealing member and the central portion of the base layer defining an enclosure, the sealing member including a sealing member aperture in fluid communication with the enclosure, and

a fluid management assembly disposed in the enclosure and configured to absorb fluid from the tissue site;

a conduit interface configured to be coupled in contact with the sealing member and including an inlet cavity and an outlet port in fluid communication with the sealing member aperture;

a fluid buffer comprising a foam configured to be positioned in direct contact with the sealing member aperture, at least a portion of the foam positioned continuously across the conduit interface relative to at least one of the inlet cavity or the outlet port such that all fluid communication between the outlet port of the conduit interface and the enclosure passes through the portion of the foam of the fluid buffer, wherein the fluid buffer is permeable to gas and liquid and is configured to have a first fluid flow resistance that is higher than a second fluid flow resistance of at least a portion of the fluid management assembly; and

a reduced-pressure source configured to be coupled in fluid communication with the enclosure through the conduit interface and the fluid buffer.

2 . The system of claim 1 , wherein the fluid buffer comprises a felted foam layer.

3 . The system of claim 2 , wherein the felted foam layer comprises a porosity between about 120 pores per inch to about 350 pores per inch.

4 . The system of claim 2 , wherein the felted foam layer is encapsulated by a fenestrated film.

5 . The system of claim 1 , wherein the fluid buffer comprises a first foam layer, a second foam layer, and a fenestrated film layer positioned between the first foam layer and the second foam layer.

6 . The system of claim 5 , wherein the fenestrated film layer comprises a liquid impermeable film including fenestrations disposed through the liquid impermeable film, and wherein the liquid impermeable film blocks the passage of liquid and the fenestrations permit the passage of liquid through the fenestrated film layer.

7 . The system of claim 5 , wherein the fenestrated film layer is a first fenestrated film layer, wherein the system further comprises a second fenestrated film layer and a third foam layer, and wherein the second fenestrated film layer is positioned between the second foam layer and the third foam layer.

8 . The system of claim 1 , wherein the inlet cavity is configured face the sealing member aperture and the outlet port is configured to be fluidly coupled to the reduced-pressure source.

9 . The system of claim 8 , further comprising a moisture indicator configured to indicate a change of state when in contact with a liquid, wherein the moisture indicator is positioned between the fluid buffer and the outlet port of the conduit interface.

10 . The system of claim 1 , further comprising an adhesive configured to extend through the apertures at least in the periphery of the base layer to contact tissue surrounding the tissue site, wherein the adhesive is disposed on a surface of at least the periphery of the sealing member that is configured to face the base layer.

Assignments (3)

Continuity (2)

References Cited (213)